pyrroles has been researched along with Hypomelanosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hartmann, JT; Kanz, L | 1 |
Al Enazi, MM; Kadry, R; Mitwali, H | 1 |
Akanay-Diesel, S; Bölke, E; Budach, W; Erhardt, A; Gerber, PA; Haes, J; Häussinger, D; Hoff, NP; Homey, B; Kürle, S; Matuschek, C; Schulte, KW | 1 |
3 other study(ies) available for pyrroles and Hypomelanosis
Article | Year |
---|---|
Sunitinib and periodic hair depigmentation due to temporary c-KIT inhibition.
Topics: Chemotherapy, Adjuvant; Follow-Up Studies; Hair Color; Humans; Hypopigmentation; Ileum; Indoles; Intestinal Neoplasms; Leiomyoma; Male; Middle Aged; Neoplasm Recurrence, Local; Periodicity; Proto-Oncogene Proteins c-kit; Pyrroles; Risk Assessment; Sunitinib; Twins, Monozygotic | 2008 |
Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
Topics: Adult; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Hypopigmentation; Indoles; Kidney Neoplasms; Male; Pyrroles; Sunitinib | 2009 |
Sunitinib induced pyoderma gangrenosum-like ulcerations.
Topics: Aged; Antineoplastic Agents; Erythema; Humans; Hyperpigmentation; Hypopigmentation; Indoles; Male; Negative-Pressure Wound Therapy; Pyoderma Gangrenosum; Pyrroles; Sunitinib; Ulcer | 2011 |